Skip to main content

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial toEvaluate the Neurological Effects of EryDex on subjects with Ataxia Telangiectasia

Open
  • Protocol code: IEDAT-04-2022
  • EudraCT code: No aplica
  • Service: General Pediatrics and Specialties
  • Principal investigator:  Gómez Andrés, David
  • Pathology: Malalties del sistema nerviós
  • Phase: Fase III
  • Status: Recruiting volunteers